Levofloxacin safety: Data from clinical trials and pharmacovigilance studies;Tolérance de la lévofloxacine, dossier clinique et données de pharmacovigilance

Therapie

Volumn 56, Issue 1, 2001, Pages 35-40

  Carbon, C ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Fluoroquinolones; Levofloxacin; Tolerance

Indexed keywords

ANTIINFECTIVE AGENT; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; HEART DISEASE; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; PHOTOTOXICITY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; TENDINITIS;

ANTI-INFECTIVE AGENTS; CLINICAL TRIALS; HUMANS; OFLOXACIN; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0035073601     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. In vitro susceptibility of Streptococcus pneumoniae to the d-and l-isomers of ofloxacine: Interpretative criteria and quality control
2. Levofloxacin, its use in infections of the respiratory tract, skin and soft tissues and urinary tract
3. Expérience internationale de la lévofloxacine
4. Effects of food and sucralfate on a single dose of levofloxacin in healthy subjects
5. The clinical pharmacokinetics of levofloxacin
6. Norfloxacin induced rheumatic disease
7. Nouvelles complications liées aux fluoroquinolones: La rupture du tendon d'Achille
8. Temafloxacine-induced hemolytic anemia and renal failure
9. Temafloxacin syndrome: Review of 95 cases
10. The withdrawal of temafloxacin. Are there implications for other fluoroquinolones?
11. Fluoroquinolones: Toxicity profiles
12. Specific toxicologic aspects of the fluoroquinolones
13. Safety profile of the fluoroquinolones
14. Clinical features and management of adverse effects of quinolone antibacterials
15. Safety and tolerability of fluoroquinolones
16. Fluoroquinolone toxicities: An update
17. Adverse drug reactions with fluoroquinolones
18. Overview of fluoroquinolone safety
19. Levofloxacin, its use in infections of the respiratory tract, skin, soft tissues and urinary tract
20. Adverse effects of the fluoroquinolones
21. Sparfloxacin Safety Group. Overview of electrocardiographic and cardiovascular safety data for sparfloxacin
22. Sparfloxacine: A new fluoroquinolone for community-acquired lower respiratory infections
23. Safety of the fluoroquinolones
24. Safety and tolerability profile of moxifloxacin
25. Cytofluorometrics analysis of chondrotoxicity of fluoroquinolone antibiotics
26. Tendon disorders with fluoroquinolones
27. Les tendinopathies achilléennes induites par les fluoroquinolones
28. Tendons et fluoroquinolones des problèmes non résolus
29. Neurotoxicity of antibacterial therapy
30. Side effects of ofloxacin in clinical trials and in postmarketing surveillance
31. Ciprofloxacin and delirium
32. Ciprofloxacin-induced psychosis
33. Neurological toxicity related to pefloxacin
34. Tolerability of fluoroquinolones antibiotics, past, present and future
35. Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding
36. Photosensitivity associated with antibacterial agents
37. Classification and structure-activity relationship of fluoroquinolones
38. Fluoroquinolone toxicities: An update
39. Renal failure with fluoroquinolones